3 evacuated off cruise ship with suspected hantavirus cluster, WHO says
A hantavirus is a virus found in the urine, saliva or excrement of deer mice and certain other infected wild rodents (Icy Macload/Getty Images)
(LONDON and BELGRADE, Serbia) — Three people have been evacuated off of the MV Hondius, a cruise ship with a suspected hantavirus cluster, the World Health Organization said on Wednesday.
WHO officials in Cape Verde told ABC News that the patients were to be transferred to ambulances waiting on the shore to receive them. The three were then to be taken to an airport, where they were expected to board a special medevac flight to the Netherlands.
“WHO continues to work with the ship’s operators to closely monitor the health of passengers and crew, working with countries to support appropriate medical follow-up and evacuation where needed,” Tedros Adhanom Ghebreyesus, the director-general of the WHO, said on social media, where he confirmed the evacuations.
“Monitoring and follow-up for passengers on board and for those who have already disembarked has been initiated in collaboration with the ship’s operators and national health authorities,” he added.
He said that “the overall public health risk remains low.”
The WHO said on Wednesday that eight suspected cases of hantavirus were recorded among passengers on the ship, an increase from the seven reported on Tuesday. Three of the cases had been confirmed by lab testing, WHO said.
“Swiss authorities have confirmed a case of hantavirus identified in a passenger from the MV Hondius cruise ship,” the WHO said on social media on Wednesday. “He had responded to an email from the ship’s operator informing the passengers of the health event, and presented himself to a hospital in Zurich, Switzerland, and is receiving care.”
There have been three deaths among the reported cases, including a married couple from the Netherlands, one of whom was confirmed to have been infected with hantavirus, authorities said.
Cape Verde officials said on Tuesday that the vessel was expected to sail to the Spanish island of Tenerife, where Spanish health authorities were to take over further investigations, including lab testing and clinical assessments, particularly for older passengers.
The leader of the Canary Islands, a Spanish archipelago off the northwestern coast of Africa, said on Wednesday that the regional government was opposed to allowing the luxury cruise ship to dock at Tenerife.
“This decision is not based on any technical criteria, nor is there sufficient information to reassure the public or guarantee their safety,” Fernando Clavijo, the president of the Canary Islands told radio station COPE, according to Reuters.
Clavijo said on social media that he had requested a meeting with the Spanish prime minister to discuss the ship. He added that the Canary Islands “always acts with responsibility, but it cannot accept decisions taken behind the backs of the Canary Islands institutions and without sufficient information to the population.”
WHO officials earlier on Wednesday said the three evacuated people were to be transferred to planes bound for both the Netherlands and Tenerife, but later updated the plan so that all would be sent to the Netherlands, officials told ABC News.
This is a developing story. Please check back for updates.
Health supplies are seen as healthcare workers receive training on administering the Ebola vaccine in a study carried out with the support of the World Health Organization as part of the fight against the Ebola virus in Kampala, Uganda on February 14, 2025. (Nicholas Kajoba/Anadolu via Getty Images)
(NEW YORK) — A deadly Ebola outbreak is continuing to spread in the Democratic Republic of Congo and Uganda, with officials on Tuesday saying there were more than 600 confirmed and suspected cases and more than 100 suspected deaths.
The World Health Organization (WHO) declared the outbreak a public health emergency of international concern, and at least one American in the DRC has tested positive, according to the Centers for Disease Control and Prevention (CDC).
Several public health experts told ABC News that while they agree with the CDC that the risk to the U.S. public is currently low, the outbreak is still concerning. They also expressed unease that the U.S. may not be prepared to adequately respond due to cuts to federal health agencies and its withdrawal from the WHO.
The experts noted cases have been found in remote regions of the DRC and Uganda, as well as urban areas, and the outbreak is growing rapidly. They added that although Ebola is a rare disease, it can be highly contagious and can lead to deadly consequences.
“We’re worried that if this outbreak is not contained, that it could spread elsewhere on the continent, which could increase the risk of the virus spreading outside of the African continent,” Dr. Jennifer Nuzzo, professor of epidemiology and director of the Pandemic Center at Brown University School of Public Health, told ABC News.
“Ebola is not as transmissible a virus as, say, a coronavirus … and that’s why I don’t think that this will ever become a pandemic scenario, but it doesn’t have to be a pandemic to be a worrisome situation,” she added.
Americans affected by outbreak
On Monday, the CDC confirmed that least one American in the DRC contracted Ebola while working in the country.
Dr. Satish K. Pillai, incident manager for the CDC’s Ebola response, told reporters that the individual developed symptoms over the weekend and tested positive late Sunday, adding that the patient and six other high-risk contacts were being moved to Germany for care and monitoring.
Serge, an international Christian missions organization, confirmed the patient is American medical missionary Dr. Peter Stafford, a board-certified general surgeon with a specialization in burn care, who was serving patients in the eastern DRC.
Pillai did not say if or when the Americans would be returning to the U.S., but experts say, even if the patient and contacts do, the risk level to the public does not change.
“We safely and effectively have [returned affected Americans home] many times before,” Emily Smith, interim chair of the department of global health at the Milken Institute School of Public Health at George Washington University, told ABC News. “It’s something we have good experience in and have always safely and effectively done. So, to me, no concerns about doing that.”
Dr. Jesse Goodman, a professor of medicine and infectious disease at Georgetown University and former chief scientist at the Food and Drug Administration, said it is encouraging that when countries such as the DRC have experienced outbreaks in the past, they have not progressed to pandemic status.
“I think the most [the U.S.] would see is the kind of limited transmission that we’ve seen in the past because this virus almost always appears that transmission is from people who have symptoms,” he told ABC News. “I think if there are cases that come to this country, I would expect limited transmission and think we have the capability to contain it.”
During the 2014 Ebola outbreak, there were two cases of suspected transmission from a patient with Ebola to nurses caring for him. The CDC has established detailed infection prevention and control procedures for health facilities that suspect they have cases of Ebola.
U.S. may not be as connected to the global health community
Even with possible U.S. capability to contain Ebola domestically, the experts who spoke to ABC News said the U.S. is likely at a disadvantage when it comes to responding to several health crises both at home and abroad due to public health capacity cuts.
Last year, the State Department announced it would be taking over programs previously run by the U.S. Agency for International Development (USAID). Secretary of State Marco Rubio said the agency — which oversaw foreign aid, disaster relief and international development programs — would no longer be providing assistance to other countries.
In previous Ebola outbreaks, USAID provided millions of dollars and operational support in response, in addition to helping with preparedness activities in neighboring countries.
Additionally, earlier this year, the U.S. officially completed its withdrawal from the WHO, with federal officials saying at the time there are “plans” in place to work with organizations on surveillance, diagnostics and outbreak response to fill in gaps left by exiting the WHO.
Brown University’s Nuzzo said the Ebola outbreak is the kind of situation public health experts warned about as USAID was gutted and the U.S. withdrew from the WHO.
“We warned that the United States would be flying blind, and it would be learning about deadly outbreaks late, and then it would be very difficult for the U.S. to respond because we would have fewer tools to do that,'” Nuzzo said. “The big worry here is that the outbreak wasn’t declared until there were more than 200 suspected cases of the virus and that is very unusual. Usually, we get signals of an outbreak much earlier.”
George Washington University’s Smith concurred, “When we are talking about public health infrastructure and global health infrastructure, we’re in a worse place today than we were two years ago.”
Nuzzo also noted that the National Institute of Allergy and Infectious Diseases, an agency within the National Institutes of Health, ended research at its high containment lab in Fort Detrick, Maryland, due to “a safety stand-down” last year.
The lab was one of the few federal facilities studying Ebola and other deadly pathogens, which Nuzzo said could have been useful in understanding the virus and developing therapies for the recent outbreak.
“So now that we have Americans potentially exposed to a virus that’s deadly, for which we have no vaccines or treatments, you can imagine how beneficial it would be to have a laboratory that can conduct world-class research to make sure we develop cures for this,” Nuzzo said. “But we don’t have it. So, we’re basically behind the curve in being ready for this.”
Goodman also said that the U.S. may not be as prepared because Health and Human Services Secretary Robert F. Kennedy Jr. has been actively shifting the department’s focus away from infectious disease management and towards chronic illnesses.
During his confirmation hearings last year, Kennedy argued that too much federal funding has been “devoted” to “infectious disease and to drug development and very little to chronic diseases.”
Goodman argued that there needs to be a focus on infectious diseases because of the threats they may pose to public health.
“I think the message here is these infectious disease, we may be done with them, but they’re not done with us,” he said. “There’s a reason that so many of us work for so many years to be prepared for whatever the next thing is because we don’t know what it is and we just need to be ready.”
Kennedy told ABC News on Monday that his agency is addressing the recent hantavirus and Ebola outbreaks.
“Yeah, we’re working on it,” Kennedy replied when asked if he was worried about the outbreaks. Kennedy did not respond when asked what his message might be to Americans who are concerned about the diseases potentially spreading in the U.S.
On Sunday, the State Department issued “Level 4 — Do not travel” advisories for Uganda and the DRC due to the outbreak.
Nuzzo said she’s worried that the U.S. hasn’t built a public health system that acknowledges viral outbreaks as recurring threats, saying the U.S. has been caught off guard with previous incidents such as COVID-19.
“We don’t do that with other recurring hazards you know; we don’t try to build FEMA in the midst of a hurricane,” Nuzzo said.
Healthcare workers walk outside the Ebola treatment centre in Beni, eastern Democratic Republic of the Congo. (2019). (Photo by Sally Hayden/SOPA Images/LightRocket via Getty Images)
(NEW YORK) – An Ebola outbreak has been confirmed in the Ituri province in Democratic Republic of the Congo, according to Africa Centres for Disease Control and Prevention.
As of the latest update, about 246 suspected cases and 65 deaths have been reported, mainly in Mongwalu and Rwampara health zones, officials said.
Africa CDC said that preliminary lab results from the Institut National de Recherche Biomédicale (INRB) have detected Ebola virus in 13 of 20 samples tested. Four deaths have been reported among laboratory-confirmed cases.
The latest outbreak comes around five months after Congo’s last Ebola outbreak was declared over after more than 40 deaths.
“Africa CDC is closely monitoring the situation and convening an urgent high-level coordination meeting today with the DRC, Uganda, South Sudan and global partners to reinforce cross-border surveillance, preparedness and outbreak response efforts,” officials said in a statement Friday.
-ABC News’ Rashid Haddou contributed to this report
In this stock image, an open bottle of Tylenol Extra Strength pain reliever is shown. (STOCK IMAGE/Getty Images)
(NEW YORK) — Taking acetaminophen, also known by the brand name Tylenol, during pregnancy had no effect on children developing autism, according to a study of over 1.5 million children in Denmark published this week.
The study was published in JAMA Pediatrics.
Researchers analyzed 1.5 million children born between 1997 and 2022. About 1.8% of those who were exposed to Tylenol during pregnancy developed autism compared to 3.0% of those who were not exposed to Tylenol.
A prior study out of Sweden looked at siblings, finding no causal link between autism and Tylenol exposure during pregnancy. There are genetic associations and environmental triggers that are likely involved, but neither Tylenol nor vaccines has been shown to be the cause of autism.
The new study out this week comes after President Donald Trump and his administration had previously urged pregnant mothers to avoid Tylenol, without substantive evidence for the claims.
“With Tylenol, don’t take it. Don’t take it,” Trump said during a press event at the White House in September. “If you can’t live, if your fever is so bad, you have to take one, because there’s no alternative to that.”
The FDA then initiated a process to update the safety label on acetaminophen to suggest that its use during pregnancy and autism were linked.
At the time, Kenvue, the maker of Tylenol, wrote in part of a statement, “We believe independent, sound science clearly shows that taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise and are deeply concerned with the health risk this poses for expecting mothers.”
At the time, medical organizations, like the American College of Obstetrician & Gynecologists, immediately pushed back, noting that Tylenol was one of the few options for pregnant women to treat pain and fever, which can be harmful when left untreated.
It is generally not recommended for pregnant women to take ibuprofen, Advil, during pregnancy due to the risk of complications.
Nevertheless, the claims made by the administration have led to confusion. A prior study found that Tylenol use in emergency departments dipped 16% immediately following the announcement by the administration.
ABC News reached out to Kenvue, the maker of Tylenol, for a statement but did not immediately hear back.
